Taurine release associated to volume regulation in rabbit lymphocytes
✍ Scribed by J. Jesús García; R. Sánchez Olea; H. Pasantes-Morales
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 512 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Rabbit lymphocytes exposed to hyposmotic media first swell and then recover their initial volume within 6 min. During volume recovery, free amino acids (FAA) decrease from 451.1 to 208 nmoles/mg protein. Taurine was the dominating FAA, accounting for 70% of the FAA pool. The time course of 3H-taurine release induced by hyposmolarity followed that of volume recovery. Efflux of 3H-taurine in an 8 min period was 17.8% (of total labeled taurine accumulated during loading) in an isosmotic medium. Reducing osmolarity to 0.87, 0.75, 0.62, and 0.5 increased this release to 24.8%, 38.1%, 56.4% and 70.9%, respectively. The volume-sensitive release of 3H-taurine was unaffected by omission of external Na+ or Ca++ and was reduced by 23% in the absence of Cl-. It was unaffected by agents disrupting the cytoskeleton or by tetraethylammonium, barium, quinidine, and gadolinium, but was 26% reduced by DIDS. Taurine release was inhibited at 4 degrees C, but was unchanged at 15 degrees C or 25 degrees C. An involvement of FAA, particularly taurine, in lymphocyte volume regulation is suggested.
📜 SIMILAR VOLUMES
## Abstract Hyposmolarity (−30%) in cultured cerebellar astrocytes raised cytosolic Ca^2+^ concentration ([Ca^2+^]~i~) from 160 to 400 nM and activated the osmosensitive taurine release (OTR) pathway. Although OTR is essentially [Ca^2+^]~i~‐independent, further increase in [Ca^2+^]~i~ by ionomycin
The release of preloaded radiolabeled taurine (TAU) from caltured rabbit Muller cells [14-21 days in vitro (DIV)] was measured before and after treatment with the following stimuli: 1) isoosmotic 65 mM KCl; 2 ) a medium made hypoosmotic by uncompensated lowering of Naf by 40-100 mM; and 3) NH,C1 ran
This work was designed to study the proliferative response of tumor-associated lymphocytes (TAL) from neoplastic effusions against autologous tumor cells and the immunophenotype pattern of TAL from neoplastic effusions and that of PBMC of the same patients. We also compared the serum levels of the c